Skip to main content

Table 4 The glucose homeostasis parameters of control and NAFLD groups

From: The role of hepatic transcription factor cAMP response element-binding protein (CREB) during the development of experimental nonalcoholic fatty liver: a biochemical and histomorphometric study

Weeks

Fasting glucose

Fasting insulin level

Insulin resistance

Control

NAFLD

Control

NAFLD

Control

NAFLD

2

73.2 ± 2.18

81.8 ± 3.07

0.70 ± 0.13

1.15 ± 0.23

0.12 ± 0.03

0.23 ± 0.04

4

72.4 ± 3.41

89.8 ± 3.35*#

0.90 ± 0.14

2.67 ± 0.16*#

0.15 ± 0.03

0.58 ± 0.02*#

6

77.2 ± 4.35

104.4 ± 5.15*#

0.95 ± 0.16

3.40 ± 0.20*#

0.17 ± 0.02

0.87 ± 0.02*#

8

74.8 ± 3.34

118.6 ± 4.08*#

0.86 ± 0.17

4.50 ± 0.39*#

0.15 ± 0.03

1.28 ± 0.06*#

10

76.6 ± 3.61

137.8 ± 3.56*#

0.76 ± 0.18

5.52 ± 0.38*#

0.14 ± 0.03

1.82 ± 0.07*#

12

80.4 ± 4.66

167.0 ± 3.26*#

0.90 ± 0.14

6.74 ± 0.39*#

0.17 ± 0.02

2.74 ± 0.12*#

14

80.6 ± 3.67

196.4 ± 5.81*#

0.94 ± 0.13

8.13 ± 0.37*#

0.18 ± 0.02

3.95 ± 0.11*#

  1. Data expressed as mean ± SE
  2. *Significant difference compared to control group at the same duration period by t test (P < 0.05)
  3. # Significant difference compared to the previous duration in the same group by paired t test (P < 0.05)